Home > Journals > The Quarterly Journal of Nuclear Medicine and Molecular Imaging > Past Issues > The Quarterly Journal of Nuclear Medicine and Molecular imaging 2009 December;53(6) > The Quarterly Journal of Nuclear Medicine and Molecular imaging 2009 December;53(6):604-17

CURRENT ISSUE
 

JOURNAL TOOLS

eTOC
To subscribe PROMO
Submit an article
Recommend to your librarian
 

ARTICLE TOOLS

Reprints
Permissions

 

REVIEWS  MOLECULAR IMAGING BEYOND NUCLEAR MEDICINE 

The Quarterly Journal of Nuclear Medicine and Molecular imaging 2009 December;53(6):604-17

Copyright © 2009 EDIZIONI MINERVA MEDICA

language: English

Hyperpolarized agents for advanced MRI investigations

Viale A., Reineri F., Santelia D., Cerutti E., Ellena S., Gobetto R., Aime S.

Department of Chemistry, University of Turin, Turin, Italy


PDF


The strong signal enhancement attainable by hyperpolarization methods has allowed the detection of heteronuclei in magnetic resonance imaging (MRI), allowing to obtain high quality images with very high signal to noise ratios in few seconds. The four methods to produce hyperpolarized molecules, i.e. the “brute force” approach, optical pumping of noble gases, parahydrogen induced polarization (PHIP) and dynamic nuclear polarization (DNP), are reported. The applications of hyperpolarized probes to MRI range from vascular imaging to interventional imaging and perfusion studies, up to the emerging and challenging field of molecular/metabolic imaging. In fact, the high signal intensities achievable by using hyperpolarized molecules make it possible to detect and image the metabolic products formed upon the administration of the hyperpolarized agent. The most striking examples are surveyed, including the use of hyperpolarized 13C-pyruvate in tumor diagnosis and stadiation, and in myocardium perfusion and activity studies, as well as the recently reported proposal of using 13C-bicarbonate as agent for pH-mapping in vivo.

top of page